(S (NP (NNP SARS-CoV-2)) (VP (VBZ is) (NP (NP (DT a) (JJ severe) (NN respiratory) (NN infection)) (SBAR (WHNP (WDT that)) (S (VP (VBZ infects) (NP (NNS humans))))))) (. .))
(S (NP (PRP$ Its) (JJS outburst)) (VP (VBN entitled) (NP (PRP it)) (PP (IN as) (NP (DT a) (JJ pandemic) (NN emergence)))) (. .))
(S (S (VP (TO To) (VP (VB get) (NP (DT a) (NN grip)) (PP (IN on) (NP (DT this)))))) (, ,) (NP (ADJP (FW outbreak) (JJ specific)) (UCP (NN preventive) (CC and) (JJ therapeutic)) (NNS interventions)) (VP (VBP are) (ADVP (RB urgently)) (VP (VBN needed))) (. .))
(S (NP (NP (PRP It))) (VP (MD must) (VP (VB be) (VP (VBD said) (SBAR (IN that) (, ,) (S (PP (IN until) (ADVP (RB now))) (, ,) (NP (EX there)) (VP (VBP are) (NP (NP (DT no) (VBG existing) (NNS vaccines)) (PP (IN for) (NP (NNS coronaviruses)))))))))) (. .))
(S (S (VP (TO To) (VP (ADVP (RB promptly) (CC and) (RB rapidly)) (VB respond) (PP (TO to) (NP (JJ pandemic) (NNS events)))))) (, ,) (NP (NP (DT the) (NN application)) (PP (IN of) (NP (IN in) (JJ silico) (NNS trials)))) (VP (MD can) (VP (VB be) (VP (VBN used) (PP (IN for) (S (VP (VP (VBG designing) (CC and) (VBG testing) (NP (NP (NNS medicines)) (PP (IN against) (NP (NNP SARS-CoV-2))))) (CC and) (VP (JJ speed-up) (NP (DT the) (NN vaccine) (NN discovery) (NN pipeline)))))) (, ,) (S (VP (VP (VBG predicting) (NP (DT any) (JJ therapeutic) (NN failure))) (CC and) (VP (NN minimizing) (NP (JJ undesired) (NNS effects)))))))) (. .))
(S (ADVP (RB Here)) (, ,) (NP (PRP we)) (VP (VBP present) (NP (NP (DT an) (ADJP (IN in) (NN silico)) (NN platform)) (SBAR (WHNP (WDT that)) (S (VP (VBD showed) (S (VP (TO to) (VP (VB be) (PP (IN in) (NP (NP (ADJP (RB very) (JJ good)) (NN agreement)) (PP (IN with) (NP (NP (DT the) (JJS latest) (NN literature)) (PP (IN in) (S (VP (VBG predicting) (NP (NP (JJ SARS-) (NNP CoV-2) (NNS dynamics)) (CC and) (NP (VBN related) (JJ immune) (NN system) (NN host) (NN response)))))))))))))))))) (. .))
(S (ADVP (RB Moreover)) (, ,) (NP (PRP it)) (VP (VBZ has) (VP (VBN been) (VP (VBN used) (S (VP (TO to) (VP (VB predict) (NP (NP (DT the) (NN outcome)) (PP (IN of) (NP (NP (CD one)) (PP (IN of) (NP (NP (DT the) (JJS latest) (JJ suggested) (NN approach)) (SBAR (S (VP (TO to) (VP (VB design) (NP (DT an) (JJ effective) (NN vaccine)))))) (, ,) (PP (VBN based) (PP (IN on) (NP (JJ monoclonal) (NN antibody))))))))))))))) (. .))
(S (NP (NNP UISS)) (VP (VBZ is) (ADVP (RB then)) (ADJP (RB potentially) (JJ ready) (S (VP (TO to) (VP (VB be) (VP (VBN used) (PP (IN as) (NP (DT an) (ADJP (IN in) (JJ silico)) (NN trial) (NN platform))) (S (VP (TO to) (VP (VB predict) (NP (NP (DT the) (NN outcome)) (PP (IN of) (NP (NP (NN vaccination) (NN strategy)) (PP (IN against) (NP (NNP SARS-CoV-2))))))))))))))) (. .))
